Cwm, LLC Roivant Sciences Ltd. Transaction History
Cwm, LLC
- $24.1 Billion
- Q4 2024
A detailed history of Cwm, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Cwm, LLC holds 1,629 shares of ROIV stock, worth $17,071. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,629
Previous 980
66.22%
Holding current value
$17,071
Previous $11,000
72.73%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$690 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$650 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$501 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$462 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$371 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.38B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...